Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2003
08/19/2003US6608064 Pharmaceutical agents for the treatment of Parkinson's disease, ADHD and microadenomas
08/19/2003US6608063 For example: (2-(3-amino-4-nitrophenyl)amino)ethyl)(6-(2,4-dichlorophenyl-5-nitropyrazin -2-yl)-amine; antidiabetic, -carcingenic and ischemic agents; nervous and cardiovascular system disorders; immunotherapy; obesity; syndromes
08/19/2003US6608061 Bisaryl compound and medicament for cancer treatment comprising the same
08/19/2003US6608048 Tricyclic protein kinase inhibitors
08/19/2003US6608043 Administering complex of hyaluronic acid and zinc to patient having arthritic disease
08/19/2003US6608037 TCF responsive element
08/19/2003US6608036 Oligonucleotide N3′→P5′ thiophosphoramidates: their synthesis and administration to treat neoplasms
08/19/2003US6608032 Medicinal compositions
08/19/2003US6607882 Regulation of endogenous gene expression in cells using zinc finger proteins
08/19/2003US6607757 At least 13% glucoside isoflavones and 0.6-1.5 parts 3 soya saponins per 1 part by weight of glucoside isoflavones; treating pre or post menopausal symptoms, breast and prostate cancer, and alcoholism
08/19/2003US6607755 Anti-aromatase pharmaceutical composition for controlling testosterone/estrone ratios
08/19/2003US6607724 Administering fragments, conformations, biological equivalent, or derivatives of antithrombin III; anticancer agents
08/19/2003US6607722 Methods for inducing the differentiation of monocytes into functional dendritic cells
08/19/2003CA2433180A1 Apoptosis promoting and suppressing substances interacting with cgi-94, and methods for screening the same
08/19/2003CA2260337C Therapeutic agents
08/19/2003CA2111083C Novel peptides, their preparation and use
08/19/2003CA2086207C Process for preparing optionally hydrogenated indigestible polysaccharides
08/15/2003WO2004087941A1 Map-kinase inhibitors as regulators of tumor-associated antigen expression
08/15/2003CA2475206A1 Map-kinase inhibitors as regulators of tumor-associated antigen expression
08/14/2003WO2003067262A2 Methods and compositions involving the hsp90 activator aha1
08/14/2003WO2003067260A1 Method for the diagnosis of a cystic ovarian carcinoma
08/14/2003WO2003067221A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects
08/14/2003WO2003066904A2 Methods for determining the response of cells to vegf and uses thereof
08/14/2003WO2003066892A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
08/14/2003WO2003066889A2 Assay for acytyltransferase or deacetylase activity
08/14/2003WO2003066881A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/14/2003WO2003066860A1 Angiogenesis inhibitors
08/14/2003WO2003066859A2 Amino acid sequences capable of facilitating penetration across a biological barrier
08/14/2003WO2003066854A1 Anticancer agents using vero toxin variants
08/14/2003WO2003066824A2 Albumin-fused kunitz domain peptides
08/14/2003WO2003066822A2 Truncated aggrecanase molecules
08/14/2003WO2003066810A2 Recombinant bovine immunodeficiency virus based gene transfer system
08/14/2003WO2003066806A2 Therapeutic use of aziridino compounds
08/14/2003WO2003066679A1 Rhamnose binding protein
08/14/2003WO2003066666A2 Compositions and methods for treatment of vitamin d deficiency
08/14/2003WO2003066661A2 Human dr4 antibodies and uses thereof
08/14/2003WO2003066659A2 Improved method for obtaining betulinic acid
08/14/2003WO2003066649A1 Immunostimulatory, covalently lipidated oligonucleotides
08/14/2003WO2003066647A2 Synthesis of inositolphosphate glycan molecules: treatment of cell proliferation disorders and metabolic disorders characterized by insulin resistance
08/14/2003WO2003066638A2 The synthesis of naturally occuring ecteinascidins and related compounds
08/14/2003WO2003066636A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
08/14/2003WO2003066630A2 Quinolinone derivatives for treating cell proliferation related disorders
08/14/2003WO2003066628A1 Oxadiazoles having antiproliferative activity
08/14/2003WO2003066621A1 Piperidine derivatives and their use as antagonists of tachykinins
08/14/2003WO2003066620A1 Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent
08/14/2003WO2003066618A1 Cytoprotective benzofuran derivatives
08/14/2003WO2003066613A1 N-phenyl-2-pyrimidine-amine derivatives
08/14/2003WO2003066608A1 Catechol bioisosteres
08/14/2003WO2003066601A1 Pyrimidine compounds
08/14/2003WO2003066594A2 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
08/14/2003WO2003066591A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient
08/14/2003WO2003066590A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient
08/14/2003WO2003066588A1 Water soluble phenylglycine derivatives
08/14/2003WO2003066579A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
08/14/2003WO2003066577A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
08/14/2003WO2003066574A1 Aromatic amino acid derivatives and medicinal compositions
08/14/2003WO2003066526A1 Method for producing platinum complexes (iv)
08/14/2003WO2003066205A2 Microcapsules having high carotenoid content
08/14/2003WO2003066087A2 Kinases involved in the regulation of energy homeostasis
08/14/2003WO2003066085A1 Albumin-fused anti-angiogenesis peptides
08/14/2003WO2003066078A1 Hiv inhibiting proteins
08/14/2003WO2003066077A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
08/14/2003WO2003066076A1 Method of protecting living body from foreign factor and composition therefor
08/14/2003WO2003066059A1 Treatment of neuroblastoma
08/14/2003WO2003066052A1 Anticancer agent comprising nitroimidazole and topoisomerase inhibitor as active ingredients
08/14/2003WO2003066050A1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds
08/14/2003WO2003066034A2 Use of compounds and compositions derived form olives for protecting cells against dna damage
08/14/2003WO2003066005A2 Ansamycins having improved pharmacological and biological properties
08/14/2003WO2003066003A2 Anti-pathogen treatements
08/14/2003WO2003065999A2 Proliferated cell lines and uses thereof
08/14/2003WO2003065991A2 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
08/14/2003WO2003065987A2 Granzyme b inhibitors
08/14/2003WO2003065974A2 Hexa-, hepta-, and octapeptides having antiangiogenic activity
08/14/2003WO2003065971A2 Non-myeloablative tolerogenic treatment with tyrphostins
08/14/2003WO2003065882A2 Non-invasive diagnostic imaging technology for mitochondria using radiolabeled lipophilic salts
08/14/2003WO2003065871A2 Methods and compositions for treating hematological disorders
08/14/2003WO2003065806A1 New immunoeffector compounds
08/14/2003WO2003065787A2 Methods and compositions for the targeting of a systemic immune response to specific organs or tissues
08/14/2003WO2003037335A8 5-heteroatom-substituted pyrazoles
08/14/2003WO2003035177A3 Optimal polymer mixtures for gastric retentive tablets
08/14/2003WO2003033499A3 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
08/14/2003WO2003032898A3 Modified human thymic stromal lymphopoietin
08/14/2003WO2003031568A8 Intracellular signaling molecules
08/14/2003WO2003029433A3 Chimeric viral vectors for gene therapy
08/14/2003WO2003022995A3 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
08/14/2003WO2003018768A3 Transmembrane protein differentially expressed in cancer
08/14/2003WO2003017935A3 Human antibodies specific for interleukin 15 (il-15)
08/14/2003WO2003013655A3 Carbonic anhydrase inhibitors
08/14/2003WO2003012051A8 Inhibitor of dna methylation
08/14/2003WO2003009813A3 Methods of treating neuropilin-mediated diseases
08/14/2003WO2003001984A3 Method and apparatus for the photomodulation of living cells
08/14/2003WO2002101048A3 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
08/14/2003WO2002099108A3 Atp-binding cassette transporter-like molecules and uses thereof
08/14/2003WO2002064083A3 Synthesis of 3-amino-thalidomide and its enantiomers
08/14/2003WO2002058626A3 Methods and compositions for the identification and treatment of neurodegenerative disorders
08/14/2003WO2002057453A3 Polypetides and nucleic acids encoding same
08/14/2003WO2002051438A3 Use of repulsive guidance molecule (rgm) and its modulators
08/14/2003WO2002029055A3 Carbohydrate-associated proteins
08/14/2003WO2002028420A3 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules
08/14/2003WO2002024887A3 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
1 ... 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 ... 2211